Global58 discovers remarkable companies, emerging businesses and the people building them — wherever they are.
Microgravity can change how a material forms. Varda has returned pharmaceutical samples from orbit; the harder question is whether that round trip can produce a medicine worth making there.
Read the story→A photograph shows a landscape. Pixxel's hyperspectral satellites measure reflected light to help ask what it is made of—and what might be changing.
Read the feature →
A machine shaped around the human body raises a practical question: what work can a general-purpose humanoid robot learn to do? That is the problem Figure is developing robots to address.
Read the feature →
Building a launch vehicle begins with the difficult work of making its parts. Agnikul's approach puts rocket engineering and manufacturing in the same conversation.
Read the feature →A road is not the only route between two places. Zipline builds drone delivery services, turning the air above a journey into part of the logistics network.
Read the feature →
Gasoline usually begins below ground. Aircela describes a different starting point: machines using air, water and renewable electricity to make it.
Read the feature →
What if indoor air became a biotechnology problem? Neoplants approaches it through the engineering of plants, rather than another conventional appliance.
Read the feature →W-8 and W-9 launched on 1 October 2026 after a $251 million financing announcement; a peer-reviewed ritonavir study now gives the manufacturing proposition evidence to examine.
Its 2026 S1 release uses video demonstrations to prompt unfamiliar tasks; September commercial disclosures put deployment, not just demos, at the centre of the story.
September’s revised Nova roadmap and announced Series E put early-2027 Pathfinder flight in view; October reporting describes hardware moving into testing, not completed orbital reuse.
On 18 October 2026, Anthropic announced a conditional 5% equity commitment to a public-benefit fund; governance and growth triggers remain to be disclosed.
A $75 million Series B announced on 6 October 2026 follows published comparisons of robotic cell-therapy operations and human handling; commercial-scale production remains the next test.
These are not awards. They are editorial classifications — the reason a story earned its place.
Global58 discovers the businesses, technologies and people building what comes next — wherever they are.
What problem exists? What did the company build? What changes if it works? Our impact reporting starts with the work, not the marketing.
A road is not the only route between two places. Zipline builds drone delivery services, turning the air above a journey into part of the logistics network.
Read the feature →Gasoline usually begins below ground. Aircela describes a different starting point: machines using air, water and renewable electricity to make it.
Read the feature →What if indoor air became a biotechnology problem? Neoplants approaches it through the engineering of plants, rather than another conventional appliance.
Read the feature →Ideas do not build themselves. A public-source look at the people who chose these problems.
Awais Ahmed / Kshitij Khandelwal
Brett Adcock
Shashank Samala / Noah McQueen
Dr. Nadine Hachach-Haram
Srinath Ravichandran / Moin SPM
Lionel Mora / Patrick Torbey
Keller Rinaudo Cliffton / Keenan Wyrobek / William Hetzler / Ryan Oksenhorn
Arun Vinayak / Sanjay Byalal
Eric Dahlgren / Mia Dahlgren
Suyash Singh / Denil Chawda / Rakshit Bhatt / Kishan Thakkar / Pranit Mehta
Will Bruey / Delian Asparouhov
Deepak Pathak / Abhinav Gupta
Andy Lapsa / Tom Feldman
Federico Parietti / Alice Melocchi
A real product, a meaningful problem and work worth understanding. A pitch or press release alone is not a story.
Published features require traceable sources, checked facts and rights-cleared assets. Original editorial graphics may replace photography. Unsubstantiated claims are not presented as findings.
No fee buys an editorial feature or the right to use the mark. Nominations are leads, not a promise of coverage.
We look for a distinctive contribution, with context and limitations. Selection is an editorial decision, not a league table or endorsement.
A mark reserved for companies editorially selected and featured by Global58.
Featured companies may display the mark across their website, press materials and social channels. Not an award, certification, accreditation or paid endorsement.
A feature is earned. Not purchased.
Mark usage and editorial citation→The 58
A carefully curated Global58 briefing featuring emerging companies, founder stories and ideas shaping business.
The 58 subscriptions are currently unavailable.